Showing results (301-310 of 723) with videos related to
Sort By:
Pageof 73
Experimental Brain Research|September 10, 2023
Motor adaptation does not differ when a perturbation is introduced abruptly or graduallyAmbika Bansal, Bernard Marius 't Hart, Udai Cauchan, et al.Journal of Medical Primatology|December 1, 1995
Characterization of the natural immune response of rhesus monkey CD4+ve T cells to the bacterial antigen streptolysin O (SLO)E M Kraakman, R E Bontrop, R Groenestein, et al.BMJ (Clinical Research Ed.)|June 22, 1991
Twenty five years of case finding and audit in a socially deprived communityJ T Hart, C Thomas, B Gibbons, et al.Annual Review of Immunology|March 23, 2004
Self- and nonself-recognition by C-type lectins on dendritic cellsTeunis B H Geijtenbeek, Sandra J van Vliet, Anneke Engering, et al.Virchows Archiv : an International Journal of Pathology|December 4, 2020
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretationCleo Keppens, Elisabeth Mc Dequeker, Patrick Pauwels, et al.Journal of Neuroinflammation|September 18, 2015
Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvantS Anwar Jagessar, Nicole Heijmans, Erwin L A Blezer, et al.European Journal of Cancer (Oxford, England : 1990)|March 27, 2012
Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinomaL C Krol, N A 't Hart, N Methorst, et al.Annals of Biomedical Engineering|November 14, 2015
Mapping 3D Strains with Ultrasound Speckle Tracking: Method Validation and Initial Results in Porcine Scleral InflationBenjamin Cruz Perez, Elias Pavlatos, Hugh J Morris, et al.Frontiers in Immunology|June 20, 2013
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple SclerosisBert A 't Hart, S Anwar Jagessar, Krista Haanstra, et al.Oncogenesis|March 30, 2018
Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategiesR C Heijkants, M Nieveen, K C 't Hart, et al.Pageof 73